Global /South Korea /Healthcare /Medical Distribution /362320

CHUNGDAMGLOBAL Co., Ltd.

362320

• KRX: 362320 • Delayed

5,310KRW 0%

3.46 USD

As of 5 June 2026, CHUNGDAMGLOBAL Co., Ltd. has a market cap of $70.29M USD, ranking #28090 globally and #1466 in South Korea. It ranks #2538 in the Healthcare sector, and #103 in the Medical Distribution industry.

Global Rank

28090

Country Rank

1466

Sector Rank

2538

Industry Rank

103

Key Stats

Market Cap

$70.29MUSD

108.05B KRW

Enterprise Value

$102.4MUSD

156.97B KRW

Revenue (TTM)

$141.42MUSD

217.39B KRW

EBITDA (TTM)

$6.01MUSD

9.22B KRW

Net Income (TTM)

$1.22MUSD

1.87B KRW

EBITDA Margin

4.2%

Profit Margin

0.9%

PE Ratio

57.1

PS Ratio

0.5

PB Ratio

0.9

EV/EBITDA

17.0

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Medical Distribution

CEO

Seokju Choi open_in_new

Founded

2017

Website

chungdamgroup.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	-0.7%	6.8%	-9.2%	-36%	-12%	-4.7%	-41%	-39%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	362320 (주) 청담글로벌 ISIN: KR7362320004 Shares Out.: Shares Outstanding: 20.348M¹ Shares Float: 9.883M² TV: TradingView: KRX: 362320 SA: Stock Analysis: KRX: 362320 YF: Yahoo Finance: 362320.KS GF: Google Finance: KRX: 362320 BA: Barron's: 362320 MS: Morningstar: XKRX: 362320	5,310 KRW	TV: TradingView: KRX: 362320 SA: Stock Analysis: KRX: 362320 YF: Yahoo Finance: 362320.KS GF: Google Finance: KRX: 362320 BA: Barron's: 362320 MS: Morningstar: XKRX: 362320

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About CHUNGDAMGLOBAL Co., Ltd.

CHUNGDAMGLOBAL Co., Ltd. distributes cosmetics and household goods. The company was incorporated in 2017 and is headquartered in Seoul, South Korea.

Similar Companies

Industry: Medical Distribution (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Hanmi Science Co., Ltd. KRX: 008930	$1.67B 2.57T KRW 2K%	21.8	South Korea
HLB Life Science Co., Ltd. KRX: 067630	$340.45M 523.33B KRW 384%	-	South Korea
HLB Therapeutics Co.,Ltd. KRX: 115450	$212.56M 326.75B KRW 202%	-	South Korea
Manyo Factory Co., Ltd. KRX: 439090	$179.06M 275.24B KRW 155%	30.1	South Korea
Ensol Biosciences, Inc. KRX: 140610	$102.01M 156.81B KRW 45%	-	South Korea
Aminologics Co.,Ltd. KRX: 074430	$82.5M 126.82B KRW 17%	36.1	South Korea

Industry: Medical Distribution (Global)

Name	Market Cap (USD) diff.	PE	Country
McKesson Corp. NYSE: MCK	$100.76B 143K%	24.0	United States
Cencora, Inc. NYSE: COR	$60.58B 86K%	37.4	United States
Cardinal Health, Inc. NYSE: CAH	$47.73B 68K%	29.6	United States
Henry Schein, Inc. NASDAQ: HSIC	$8.47B 12K%	22.6	United States
Sinopharm Group Co. Ltd. SHEK: 1099	$7.48B 58.61B HKD 11K%	7.2	China
Galenica AG SIX: GALE	$5.3B 4.2B CHF 7K%	23.0	Switzerland

chevron_leftBack